Equal benefits to our residential courses, without the travel.View Courses
All our courses. 12 months access. One flat fee.More Information
Non-members can signup to keep up to date with RQA news and events.Add your details now
12th February 2021
Since before the end of the transition period on 31st December 2020, MHRA have been working hard to provide the guidance you need to become familiar with the pharmacovigilance requirements for UK marketing authorisation holders (MAH) which are set out in a revised legal framework. In this blog post, Kiernan Trevett has pulled together all the sources of guidance that MHRA have published so far, as well as information on where to go if you still have questions.